Kjartan Thorsson
CEO / Co-Founder

Prescriby develops a digital treatment system that utilizes data-driven software to enhance the safety and monitoring of opioid prescriptions, ensuring personalized care plans and ongoing patient support. This approach addresses the lack of resources and tools in healthcare systems that often leave patients without adequate follow-up, increasing the risk of addiction.
Raised to date
$2.1MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

CEO / Co-Founder
Healthcare systems often lack the resources and tools to effectively monitor patients prescribed addictive medications, leading to inadequate follow-up and increased risk of addiction. Patients may be discharged without a personalized treatment plan or sufficient support for gradually reducing dosages, resulting in prolonged use and potential dependence.
Prescriby offers a data-driven digital treatment system designed to enhance the safety and monitoring of opioid and other addictive medication prescriptions. The platform provides personalized care plans and ongoing patient support, enabling clinicians to proactively manage prescriptions from the initial dose and facilitate tapering treatments for patients who have developed physical tolerance or dependence. By combining a clinically validated workflow with software, Prescriby aims to improve patient access to safer treatments, reduce treatment costs, and mitigate the risk of addiction. The system also generates automatic reports on key quality indicators, providing clinicians and policymakers with improved insights into operations and outcomes.
Prescriby targets healthcare systems, clinicians, and policymakers seeking to improve the safety and effectiveness of addictive medication prescriptions, reduce the risk of patient dependence, and enhance overall patient care.